Live Breaking News & Updates on Corium

Stay updated with breaking news from Corium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Corium's Novel ADHD Medication AZSTARYS® (Serdexmethylphenidate and Dexmethylphenidate) Had No Clinically Significant Impact on Children's Weight and Height Growth Rate

/PRNewswire/ Corium, LLC, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS). ....

United States , Ann Childress , Adolesc Psychopharmacol , Us Centers For Disease , Prnewswire Corium , Adolescent Psychopharmacology , Behavioral Medicine , Chief Medical Officer , Disease Control , Important Safety Information , Attention Deficit Hyperactivity Disorder , Pre Existing Psychosis , Manic Episode , Bipolar Disorder , New Psychotic , Manic Symptoms , Prescribing Information , Medication Guide , Growth Velocity , Children With , Hyperactivity Disorder Treated ,

CORIUM TO PRESENT AT 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

/PRNewswire/ Corium LLC (Corium) announced that President and Chief Executive Officer, Perry J. Sternberg, will present at the 41st Annual J.P. Morgan. ....

United States , Perryj Sternberg , Heather Gartman , Prnewswire Corium , Chief Executive Officer , Healthcare Conference ,

Corium Launches ADLARITY® (donepezil transdermal system) for Patients with Alzheimer's Dementia

/PRNewswire/ Corium, Inc., a fully-integrated biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS). ....

United States , United Kingdom , Gurnet Point , Perry Sternberg , Us Centers For Medicare , Us Centers For Disease , Corium Inc , World Health Organization , Prnewswire Corium Inc , Medicaid Services , Drug Administration , Chief Executive Officer , Lori La Bey , World Health , Disease Control , Point Capital , Prescribing Information , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Biotechnology , Banking Amp Financial Services , Clinical Trials Amp Medical Discoveries ,

Open Label Safety Study Shows Improved Sleep for Children With ADHD After One Month of AZSTARYS® (serdexmethylphenidate and dexmethylphenidate)

/PRNewswire/ Corium, Inc., a fully integrated biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS). ....

United States , United Kingdom , Gurnet Point , Serdexmethylphenidate Dexmethylphenidate , Andrewj Cutler , Gregw Mattingly , Meg Corliss , Jose Estrada , Greg Mattingly , Adolesc Psychopharmacol , Annc Childress , Laboratory Classroom Study Of Serdexmethylphenidate , Psych Congress , Corium Inc , American Professional Society , Prnewswire Corium Inc , Washington University School Of Medicine , Dexmethylphenidate Effects , Sleep Habits Questionnaire , Washington University School , Chief Medical Officer , Open Label Safety , Children With , Important Safety Information , Attention Deficit Hyperactivity Disorder , Pre Existing Psychosis ,

Serdexmethylphenidate, a Prodrug of Dexmethylphenidate and Contained in Corium's ADHD Medication AZSTARYS® (serdexmethylphenidate and dexmethylphenidate), Has Low Relative Potential for Abuse

/PRNewswire/ Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS). ....

United States , United Kingdom , Gurnet Point , Meganj Shram , Altreos Research Partners Inc , University Of Toronto , Corium Inc , Prnewswire Corium Inc , Current Medical Research Opinion , Current Medical Research , Chief Medical Officer , Altreos Research Partners , Adjunct Professor , Drug Liking , Liking Emax , Ark Biopharmaceutical , Gurnet Point Capital , Important Safety Information , Attention Deficit Hyperactivity Disorder , Pre Existing Psychosis , Manic Episode , Bipolar Disorder , New Psychotic , Manic Symptoms , Prescribing Information , Point Capital ,